A fraction of the low-density lipoprotein (LDL) internalized by cells via receptormediated endocytosis follows a short-circuit pathway, termed "retro-endocytosis," that results in the rapid exocytosis of ligand. Results from the current study suggest that retro-endocytosis of LDL in human fibrobiasts is caused by resurfacing of endocytotic vesicles that contain both free and receptor-bound ligand, resulting in discharge of vesicular contents and in spontaneous dissociation of LDL from its receptor. The bulk of the released LDL particles had the same size, density, and immunogenic properties as native LDL, indicating that they were discharged intact. Some of the retro-endocytosed LDL was larger than native LDL, and some exhibited altered sedimentation properties. When fusion of endosomes with lysosomes was inhibited by chilling cells to 18° C, the proportion of intraceliular LDL subsequently released was unaffected, suggesting that retro-endocytosis does not require lysosomal participation. Furthermore, the shorter the internalization phase, the greater was the proportion of LDL subsequently released, suggesting that LDL was discharged from compartments formed early in endocytosis.
internalization of receptor-LDL complexes into coated vesicles. The complexes are transported via multiple vesicle fusions to large tubular structures called endosomes. Through the action of an ATP-driven proton pump, the endosomes are acidified, causing the ligand to dissociate from its receptor. The receptor then returns to the cell surface where it initiates another cycle of endocytosis and the bulk of the LDL is delivered to lysosomes where it is degraded. A fraction of the internalized LDL appears to escape lysosomal targeting and is rapidly discharged, apparently intact, into the extracellular medium by a process we have termed "retro-endocytosis." 2 The intraceliular movement of ligands to selective regions of the cell depends on factors that regulate interaction of the transport vesicles with specific membrane components and upon sorting of vesicle contents. The mechanisms involved in targeting, sorting, and receptor recycling are poorly understood. The fate of vesicle contents appears to vary with the cell type and the ligand. Endocytosed con-tents are usually delivered to lysosomes except in certain specialized cell types where delivery to storage granules (fetal yolk sac), 3 Golgi elements (neuroblastoma cells), 4 or across cells (neonatal intestinal epithelial cells) 5 has been observed. Recent evidence has shown that a variety of ligands internalized by receptor-mediated endocytosis follow a short circuit pathway that does not lead to degradation but results in the rapid exocytosis of intact ligand. 2fM > The occurrence of exocytosis in cultured smooth muscle cells and fibroblasts 2 ' 8 as well as isolated hepatocytes, 7 reticulocytes, 8 and macrophages 9 suggests that retro-endocytosis may be a general phenomenon.
We have previously shown 2 that retro-endocytosis is a rapid, temperature-dependent process that occurs following the binding and internalization of LDL by specific cell-surface receptors. The present study is focused on the mechanism(s) of retro-endocytosis and, in particular, on the following questions: (1) Is the LDL structurally altered during retro-endocytosis? (2) From which intracellular compartment is the internalized LDL released? (3) Can retro-endocytosis of LDL be modulated by agents that affect vesicular transport processes? Results suggest that most of the released LDL particles were structurally similar to native LDL. Receptor-ligand complexes, as well as free ligand, appear to be cycling from prelysosomal intracellular compartments to cell-surface locations. Flux through this short-circuit pathway is facilitated by agents such as chloroquine and methylamine that induce excessive intracellular accumulation of undegraded LDL, as well as by agents like monensin that raise the pH of endosomes.
Methods

Cells and Llpoprotelns
Human skin fibroblast strains previously characterized as LDL-receptor-normal (GM 3348) and LDLreceptor-internalization-defective (GM 2408A) were obtained from the Human Genetic Mutant Cell Repository (Camden, New Jersey). In addition, skin fibroblasts were established from a skin biopsy obtained from the ventral surface of the thigh of normocholesterolemic subjects and were confirmed as LDL receptor-normal. There were no systematic differences between the different normal skin fibroblast lines. The cells were maintained in culture as described previously 10 and were used between Passages 5-15. Cells were plated at 0.5 x 10 5 cells per 35 mm dish, and cultures in late logarithmic growth (Days 5 to 7) were used in experiments.
Human LDL (density = 1.019-1.063 g/ml) and lipoprotein-deficient serum (density >1.25 g/ml) (LPDS) were prepared by discontinuous gradient centrifugation in a vertical rotor, and the LDL was labeled with 125 I using the iodine monochloride method as modified for lipoprotein. 11
Binding, Internalization, Retro-endocytosis and Degradation of 125 I-LDL
The retro-endocytosis of 125 I-LDL was determined by using a pulse-chase procedure as previously described. 2 Before each experiment, the number of LDL receptors was up-regulated by incubation of cells with culture medium containing 10% human LPDS. The cell layers then received lipoprotein-deficient culture medium containing the indicated concentration of 125 I-LDL and were incubated at 37° C for the indicated time (pulse period). When pulse incubations were performed at 4° C, the medium was buffered with 10 mM N-2-hydroxy-ethyl-piperazine-N^-ethanesulfonic acid (HEPES), pH 7.4. The cells were chilled on ice and each layer was washed four times with 0.2% bovine serum albumin in phosphate-buffered saline, (PBS) pH 7.4, and three times with PBS at 4° C. Surface-bound LDL was removed by incubation of the cell layers with PBS containing 4 mg/ml sodium heparin (Sigma) or 4 mg/ml dextran sulfate at 4° C for 45 to 60 minutes. The cells were rinsed three times with PBS and then incubated for up to 2 hours at 37° C in medium containing 10% LPDS and the indicated concentration of unlabeled LDL (chase period). Where specified, the cells were chase-incubated with serum-free medium containing 0.2% albumin without unlabeled LDL. The chase period culture medium was retained and the cells were washed three times with PBS at 4° C. The 125 l-radioactivity (intracellular LDL after chase) and protein content were then determined in NaOH-solubilized cell layers. The release of 125 l-protein and 125 l-degradation products from cells was determined after incubation of the chase medium with an antibody to LDL (see immunoprecipitation of 125 l-protein). As indicated, 30 nM chloroquine (Sigma), 5 mM methylamine (Sigma), and/or 25 fiM monensin (Calbiochem-Behring Corporation) were used. In experiments where monensin dissolved in ethanol was used, 0.25% ethanol was added to dishes not receiving monensin. Unless indicated otherwise, each data point for the figures and tables represents the mean of determinations on duplicate dishes.
Immunoprecipitation of 125 l-Proteln
Sheep immune serum raised against human LDL was prepared as described by Albers et al. 12 Gel diffusion studies indicated that this antibody did not react with HDL (free of apoprotein B), apoproteins A-l, A-ll, C-l, C-ll, C-lll, D, E, or the d > 1.21 g/ml plasma fraction. Immunoprecipitation of 125 l-protein was performed by adding 0.2 ml sheep immune serum to 1 ml chase medium containing 35 to 50 p,g/ml carrier LDL protein followed by incubation at 37° C for 1 hour and then 4° C for 18 to 24 hours. This proportion of LDL to immune serum gave maximum precipitation. The immune precipitate was isolated by centrifugation, washed by recentrifugation in PBS, and counted for 125 I. Trichloroacetic acid (TCA; final concentration of 10%), was added to the super-natant and the amount of nonimmunoprecipitable 12S l-protein was determined by counting the washed TCA precipitate for 125 I. An aliquot of the acid supernatant was counted to determine 12S I-LDL degraded during the chase period. The extent of retro-endocytosis was determined as the amount of 125 l-radioactivity precipitated by an antibody to LDL. Immunoprecipitation of chase medium using affinity purified rabbit antihuman LDL gave similar results. The "retro-endocytosis index" is defined as the ratio of immunoprecipitable 125 l-protein released during the chase to the intracellular content of 125 I before the chase. As the total 125 I in the cell at the end of the pulse would represent both 125 I in the form of native LDL (immunoprecipitable) as well as some 125 I that is partially or completely degraded (may not be immunoprecipitable), the retro-endocytosis index would represent a minimum value.
Immunological studies revealed that, although approximately 95% of the 125 l-protein material present during the pulse incubation reacted with an antibody to LDL, only 50% to 70% of that released upon subsequent incubation in isotope-free chase medium was immunoreactive. Particles released during the chase that did not react with anti-LDL immune serum were separated from particles that had the same size and immunogenic properties as native LDL by gel filtration (Biogel A-5m; see molecular sieve chromatography). Autoradiographic analysis of sodium dodecyl sulfate-polyacrylamide gel electrophoretic patterns of nonimmunoreactive 125 l-particles purified by gel filtration yielded molecular weight species that appeared identical with apolipoproteins A-l and C-l through C-l 11. Isopycnic sucrose density gradient centrifugation indicated that these nonimmunoreactive particles exhibited a density of greater than 1.12 g/ml. These particles were found to be present in the 125 I-LDL preparation (<1%). It appears that the release of nonimmunoreactive 125 l-particles was the result of reversible binding to the cell surface of a radiolabeled HDL-like particle present in the original 125 I-LDL preparation.
Sedimentation Velocity Centrifugation
Ultracentrifugation of lipoprotein samples was carried out using a two-step KBr gradient. Samples containing 125 l-protein in 2 ml medium containing 10% lipoprotein-deficient serum were adjusted to a density of 1.080 g/ml with solid KBr and layered beneath 15 ml of a 1.045 g/ml solution. Tubes were centrifuged at 65,000 rpm for 5.5 hours at 10° C in a Sorval 865B vertical rotor. Gradients were fractionated by drainage from the bottom of the tube. Fractions of 14 drops were collected and assayed to determine the amount of immunoreactive 125 l-protein by incubation with anti-LDL immune serum (recovery >95%).
Molecular Sieve Chromatography
Chromatography of samples were carried out on a Biogel A-5m column (200-400 mesh, 1.5 x 90 cm) (Biorad), equilibrated with 100 mM Tris-HCI (pH 7.5) containing 150 mM NaCI and 10 mM EDTA. Samples contained 12S l-protein in medium containing 10% LPDS and 500 ^g unlabeled LDL. A sample volume of 3 ml was applied and the column eluted with the above buffer at a flow rate of 6-8 ml/h. Fractions of 60 drops (approximately 2 ml) were collected and assayed to determine the amount of immunoreactive 125 l-protein by incubation with anti-LDL antibody (recovery >90%). Blue dextran and 12S I were used for the location of the void and total bed volume, respectively.
Results
To examine the possibility that structural modification of LDL could occur during retro-endocytosis, the physical properties of retro-endocytosed LDL were compared with those of native LDL. In these studies, fibroblasts were pulse-labeled with 12S I-LDL at 37° C, exposed to heparin to remove surface-bound 125 I-LDL, and subsequently incubated in isotope-free chase medium at 37° C. The extent of retro-endocytosis was determined as the amount of 125 l-radioactivity present in the chase medium that was precipitated by an antibody to LDL. Molecular sieve chromatography demonstrated that approximately 75% of the immunoreactive 12S l-particles released into the chase medium eluted at the same position as pulse 125 I-LDL and heparin-released 125 I-LDL ( Figure  1 ). The remainder were larger than native LDL, eluting in the void volume. Sedimentation velocity centrifugation indicated that approximately 70% of the chase-released immunoprecipitable 125 l-protein exhibited a distribution profile like that of native 12S I-LDL. The remaining particles either were retained in the density 1.080 g/ml fraction at the bottom of the tube or exhibited a flotation velocity greater than LDL, floating to the top of the tube ( Figure 2 ). It appears that different lipoprotein fractions were released from fibroblasts: 1) intact LDL, 2) higher molecular weight particles, and 3) particles with altered sedimentation properties.
Our earlier observations indicated that retro-endocytosis was a rapid, temperature-sensitive process that occurred following the binding of LDL by specific cell-surface receptors. 2 Experiments in which heparin was used to release surface-bound LDL before the chase period supported the concept that exocytosis of LDL was taking place, rather than the dissociation of surface-bound LDL. To establish this point, the metabolism of 125 I-LDL by a mutant fibroblast strain, prevously characterized as LDL-receptor-internalization-defective (GM 2408A), was examined ( Table 1 ). The inability of the mutant fibroblast strain to internalize receptor-bound LDL was evident from the low intracellular concentration and rate of degradation of LDL in relation to the amount bound. The LDL-receptor internalization-defective cell strain released less LDL than receptor-normal cells, even though the mutant strain bound the same or more LDL than the receptor-normal strain.
To obtain further support for the concept of LDL exocytosis, the effects of agents that perturb vesicular transport but do not substantially alter the binding of LDL to cell surface receptors were examined ( Table 2) . Weak bases were utilized to impair the delivery of LDL to lysosomes and increase organelle pH. 13 Fibroblasts pulse-labeled with 125 I-LDL for 18 hours in the presence of chloroquine (30 /xM) or methylamine (5 mM) retro-endocytosed two-to fourfold more LDL than control cells loaded in the ab- Figure 1 was followed. Ultracentrifugation of 125 l-protein particles in the pulse and chase medium was carried out as described in Methods. Fractions were collected and assayed to determine the amount of immunoprecipitable 125 l-protein. Fraction 1 represents the most dense fraction (-1.080 g/ml), and fraction 40 represents the least dense (-1.045 g/ml). The indicated fibroblast strains were pulse-labeled for 4 hours with 20 /ug/ml 125 I-LDL, treated with heparin, and chase-incubated for 30 minutes in lipoprotein-deficient medium containing 20 ug/ml unlabeled LDL. The pulse-medium was analyzed for its content of noniodide TCA-soluble 25 l-degradation products. The 1 (-radioactivity released by heparin and the intracellular content of 125 l-radioactivity after the chase were also determined. The chase medium was analyzed for its content of immunoprecipitable 125 l-protein. Data are mean values of duplicates (Expt. 2) or mean values ± SEM of quadruplicate dishes (Expt. 1).
*LDL receptor activity was up-regulated for 16 hours only.
sence of drugs. In view of the ability of chloroquine to prevent down-regulation of LDL receptor activity, 14 control cells were pulse-incubated for only 4 hours so that the amount of 125 I-LDL bound before the chase in control and chloroquine-treated cells was similar. Increased retro-endocytosis was associated with a massive intracellular accumulation of LDL during the loading period. The addition of weak bases directly to the chase medium had little effect on the release of LDL, suggesting that their effect on retroendocytosis was secondary to their ability to promote cellular accumulation of undegraded LDL. Molecular sieve chromatography of lipoprotein particles released from fibroblasts revealed that loading in the presence of chloroquine for 18 hours enhanced the amount of particles that fractionated in a position similar to native LDL, as well as those that appeared to be larger than LDL (Figure 3) .
To approach the question of whether LDL was being retro-endocytosed before or after the fusion of ligand-containing vesicles with lysosomes, the effect of temperature was studied. At temperatures below 20° C, ligands are internalized by endocytosis, but the fusion of endosomes with lysosomes is selectively inhibited. 15 We have recently demonstrated 16 in the case of LDL, that endocytosis and receptor recycling occur at temperatures (<20° C) at which LDL degradation is blocked. To test whether retro-endocytosis can occur without lysosomal participation, fibroblasts were pulse-incubated at 37° C or 18° C with 125 I-LDL for various lengths of time, and retro-endocytosis was monitored by reincubation at the same respective temperature for 2 hours (Figure 4 ). At 18°C , 125 I-LDL degradation was inhibited (Figure 4 A) , while intracellular accumulation still occurred, albeit at a slower rate than at 37° C (Figure 4 B) . At both Fibroblasts were pulse-labeled with 40 ug/ml 125 I-LDL for the indicated times, treated with heparin and chase-incubated for 2 hours in lipoprotein-deficient medium containing 40 ug/ml unlabeled LDL. Where indicated, 30 uM chloroquine and 5 mM methylamine were employed. The ^-radioactivity releasable by heparin and the intracellular content of 125 l-radioactivity after the chase incubation were determined. The chase medium was analyzed for its content of immunoprecipitable 125 l-protein and 125 l-degradation products. Data are mean values ± SEM of the triplicate dishes. (open symbols) for the indicated times with 40 ^g/m 1 2 5 I-LDL, treated with heparin, and chase-incubated in lipoprotein-deficient medium containing 40 /xg/ml unlabeled LDL for 2 hours at the same temperature used during the pulse incubation. When incubations were performed at 18° C, the medium was buffered with 10 mM HEPES (pH 7.4). The amounts of immunoprecipitable 125 l-protein (circles) and 125 l-degradation products (triangles, dotted line) released with the chase medium were determined and the cell layer was analyzed for intracellular 125 I-LDL after the chase incubation. The intracellular content of 125 l-radioactivity before the chase (squares) is the sum of the intracellular 125 l-radioactivity remaining after the chase, plus immunoprecipitable 12 *l-protein, plus 125 l-degradation products released during the chase. The retro-endocytosis index is the ratio of immunoprecipitable 12S l-protein released in the chase to the intracellular content of 1 2 5 Iradioactivity before the chase. Data in the inset is from a separate experiment in which cells were chase-incubated at 37° C for up to 4 hours. temperatures, the amount of LDL retro-endocytosed in 2 hours increased with increasing loading time (Figure 4 A) . The fact that retro-endocytosis occurred at 18° C suggested that fusion of endosomes with lysosomes was not essential for the exocytosis of intact LDL. The proportion of LDL retro-endocytosed also varied with the length of time cells were exposed to LDL during the loading phase. The shorter the loading phase, the greater was the proportion of intracellular LDL retro-endocytosed (Figure 4 C) . Furthermore, the proportion of intracellular LDL retro-endocytosed was the same at both temperatures. The ratio of released LDL to intracellular LDL has been used as a convenient measure of the efficiency of retro-endocytosis and will be referred to as the "retro-endocytosis index". These results support the hypothesis that LDL was retro-endocytosed from a prelysosomal compartment. Moreover, the finding that the retro-endocytosis index was higher after the first few minutes of exposure to LDL suggested that LDL is released from endosomes formed early in the endocytic pathway.
Because rapid receptor recycling may present a possible mechanism by which cells could release LDL previously internalized by the LDL receptor pathway, we evaluated the effect of monensin on retro-endocytosis. Monensin has been shown to raise the pH of normally acid intracellular compartments, 17 inhibit receptor recycling, 18 prevent dissociation of receptor-ligand complexes within endosomes, 19 and inhibit transfer of ligand from endosomes to lysosomes. 20 That monensin was effective in reducing LDL receptor binding activity was confirmed by the fact that heparin-releasable 1 2 5 I-LDL was reduced by 65% when fibroblasts were pulse-incubated for 30 minutes with 25 ^.M monensin ( Table 3 ). The expected inhibition of LDL degradation was also observed (>90%). Despite a reduction in the amount of LDL endocytosed, the ionophore increased retro-endocytosis (60% to 200%). With cells loaded in the absence of monensin, its inclusion in the chase phase of the experiment alone was sufficient to increase both the amount of LDL released and the retro-endocytosis index. Even with cells loaded for 18 hours in the presence of chloroquine, the inclusion of monensin in the chase medium stimulated retro-endocytosis. This combined drug treatment dramatically increased the amount of LDL released (40-fold) and the retro-endocytosis index (10-fold).
One possible mechanism to explain retro-endocytosis is that a proportion of the internalized LDLreceptor complexes recycle to the cell surface where some of the LDL dissociates from its receptor and is released into the medium. Agents that block acidification of endocytic vesicles, such as monensin and chloroquine, may enhance the process by preventing intracellular LDL-receptor dissociation. 19 To test this possibility, preloaded fibroblasts were incubated at 37° C in culture medium containing agents known to promote the dissociation of LDL from its receptor, The conditions outlined in Table 2 were employed. Fibroblasts not exposed to monensin (25 /AM) received 0.25% ethanol. The retro-endocytosis index is defined as the ratio of immunopredpitable 125 l-protein released (RE) to the intraceiluiar content of 125 l-radioactivity before the chase (l b = l a + RE + D). Data are mean values + SEM of triplicate dishes.
including dextran sulfate, sodium heparin, and EGTA (Table 4 ). In each case, the amount of LDL retro-endocytosed was considerably higher if the chase medium contained a dissociating agent, suggesting that the return of LDL-receptor complexes. Similar results were observed with cells treated with chloroquine or monensin.
The observed increase in retro-endocytosis caused by dissociating agents was not merely due to the discharge of residual LDL from the cell surface. Fibroblasts were pulse-labeled with 40 ^g/ml 125 I-LDL for the indicated times, treated with heparin, and chaseincubated for 2 hours in serum-free medium containing 0.2% albumin. Where indicated, 30 i*.M chloroquine, 25 /iM monensin, 4 mg/ml dextran sulfate, 4 mg/ml heparin, and 3 mM EGTA, pH 7.6, were employed. Other conditions were the same as those described in Table 3. *p < 0.02; tp < 0.001.
Control value used for statistical evaluation (unpaired comparison) for each condition of the pulse incubation. §Dishes contained 0.25% ethanol.
When cells were pulse incubated at 4° C, a temperature that allows binding but prevents internalization, the inclusion of dextran sulfate in the chase medium had no effect on the release of residual surfacebound LDL ( Figure 5 ). In contrast, after loading at 37°C , retro-endocytosis was increased by the addition of dextran sulfate to the medium. Since the amount of LDL bound to the cells was approximately the same after the 37° C and 4° C loading periods, dextran sulfate must have stimulated release of LDL from within the cell, suggesting the return of LDLreceptor complexes to the cell surface.
The time-course of the reappearance of LDL at the cell surface was studied under conditions that dramatically increase retro-endocytosis, i.e., preloading in the presence of chloroquine and subsequent exposure to monensin during the chase phase ( Figure  6 ). The amount of LDL on the cell surface was assayed by exposing fibroblasts to a second 4° C hep- Figure 6 . The increase in cell-surface 125 I-LDL as a function of chase time under conditions that enhance retroendocytosis. One set of fibroblasts were pulse-labeled with 5 ^g/ml 125 I-LDL for 18 hours in the presence of 30 ^M chloroquine. Monensin (25 juM) was present during the final 15 minutes of the pulse period. The cells were treated with heparin containing 10% LPDS at 4° C and chaseincubated at 37° C for the indicated time in serum-free medium containing albumin with chloroquine and monensin as described in the Methods section. For the zero time value, cold-chase medium was added and immediately removed. The chase medium was analyzed for immunoprecipitable 125 l-protein and 125 l-degradation products (A). After the chase, the cells were washed once with PBS containing albumin, chilled, and retreated with heparin at 4° C for 1 hour. The medium was collected and analyzed for its content of 125 l-radioactivity (B). The same procedure was followed using more fibroblasts, substituting unlabeled LDL for 125 I-LDL After the second treatment with heparin, the cells were chilled, washed three times with PBS containing albumin and then assayed for LDL-receptor-activtty by incubation at 4° C with lipoprotein-deficient medium containing 5 /xg/ml 125 I-LDL and 10 mM HEPES (pH 7.4). The cells were washed seven times as decribed in Methods, and the 12S l-radioactivity associated with NaOH-solubilized cell-layers measured (C). arin treatment after the pulse-chase procedure. To estimate the relative number of receptors left on the cell surface after the chase, another group of cells was incubated with unlabeled LDL during the pulsechase procedure, exposed to heparin at 4° C, and subsequently incubated with 125 I-LDL at 4° C. Both the amounts of LDL retro-endocytosed into the chase medium (Figure 6 A) , as well as the amount of 125 I-LDL released during the postchase heparin treatment (Figure 6 B) , increased rapidly within the first minutes of the chase. In contrast, the relative number of functionally active LDL receptors (Figure 6 C) decreased during the chase period, as would be expected if chloroquine and monensin were reducing the rate of receptor recycling. These data are consistent with the hypothesis that LDL-receptor complexes are returning from intracellular compartments to the cell surface.
Discussion
We have previously demonstrated that a fraction of the LDL internalized via receptor-mediated endocytosis escapes lysosomal degradation and instead enters a short-circuit pathway, termed "retro-endocytosis," which results in the rapid discharge of LDL from fibroblasts and smooth muscle cells. 2 The present study was conducted to identify and characterize the cellular mechanism(s) involved in the retro-endocytosis of LDL and evaluate the changes in the physical properties of LDL processed by this pathway.
When the possibility that structural modification of LDL could occur during retro-endocytosis was examined, observations indicated that the bulk of the released LDL particles were structurally identical to native LDL, having the same size, density and immunogenic properties. However, some of the released LDL (approximately 20%) was larger than native LDL and some exhibited altered sedimentation properties, suggesting that cellular processing had occurred. It is not known if these two populations of altered LDL particles are related. Recently, Greenspan and St. Clair 21 showed that some of the LDL retro-endocytosed from monkey-skin fibroblasts had a greater density than the parent monkey LDL. In addition, they showed that the retro-endocytosed material was less immunoreactive with monkey LDL immune serum than native LDL. Our initial observations indicated that 30-50% of the 12s l-protein released from human fibroblasts was not recognized by human LDL immune serum. Subsequent studies, however, demonstrated that the release of the nonimmunoreactive 12S l-particles was the result of reversible binding to the cell surface of a radiolabeled HDL-like particle present in the original 125 I-LDL preparation (see Methods section).
Results with skin fibroblasts derived from a patient with familial hypercholesterolemia confirmed that retro-endocytosis of LDL is dependent upon the prior internalization of LDL by the LDL receptor. The mutant fibroblast strain, previously characterized as LDL-receptor-internalization defective, released less LDL than receptor-normal fibroblasts, even though the mutant strain had a normal ability to bind LDL. These results support the concept that release is the expression of retro-endocytosis from intraceiiuiar sites rather than the dissociation of residual LDL from surface sites. When considering the intraceiiuiar compartment(s) involved, several lines of evidence indicate that retro-endocytosis does not require the participation of lysosomes. First, the particle does not appear to be degraded. Second, kinetic studies indicate that retro-endocytosis occurs rapidly, before LDL has reached the lysosomal compartment. Third, retro-endocytosis occurs at temperatures of 20° C or less, at which fusion of endosomes with lysosomes is inhibited. 1522 We have previously demonstrated 16 that LDL endocytosis and receptor recycling continue to occur at temperatures of 20° C or less at which LDL degradation is blocked. Current results indicate that the proportion of intraceiiuiar LDL retro-endocytosed was similar at 37° C and 18° C. Furthermore, the shorter the intemalization phase, the greater the proportion of LDL that was subsequently released, suggesting that LDL is released from endosomes formed early in the endocytic pathway. Finally, lysosomotrophic inhibitors, agents known to block LDL degradation, enhanced the amount of LDL retro-endocytosed.
Insight into the cellular mechanism involved in retro-endocytosis was provided by studies using weak bases and ionophores, two classes of agents with similar modes of action. Both classes have been shown to raise the pH of normally acidic compartments, 1723 lower the rate of receptor recyling, 18 prevent dissociation of receptor-ligand complexes within endosomes, 19 and inhibit transfer of ligand from endosomes to lysosomes. 20 Results from the present study indicate that both types of agents stimulate retro-endocytosis. Fibroblasts loaded with LDL in the presence of chloroquine or methylamine retro-endocytosed two-to eightfold more LDL than control cells loaded in the absence of drug. The proportion of intraceiiuiar LDL retro-endocytosed (retro-endocytosis index) was not affected by weak bases, suggesting that their effect on retro-endocytosis was secondary to their ability to cause excessive intraceiiuiar accumulation of undegraded LDL. In contrast, exposure to monensin increased the retro-endocytosis index threefold, indicating that the ionophore was directly influencing the mechanism of LDL release. The combined effect of weak base and ionophore action was additive, elevating the amount retro-endocytosed to 40-fold, as well as the retro-endocytosis index to 10-fold. Chloroquine and methylamine have recently been shown 21 to enhance the amount of monkey LDL retro-endocytosed by monkey skin fibroblasts.
Current results showed a close association between retro-endocytosis of LDL and the rapid resurfacing of LDL still bound to its receptor. Resurfacing of LDL-receptor complexes could be demonstrated by treatment of cells with agents that specifically promote dissociation of LDL from its receptor, such as dextran suflate, heparin, or EGTA. Addition of these agents to the medium enhanced retro-endocytosis of LDL. Furthermore, when LDL-loaded cells were treated with heparin at 4° C to remove surface-bound ligand, a new pool of heparin-releasable LDL appeared on the cell surface within minutes after warming the cells to 37° C. Since LDL does not bind to its specific receptor below pH 6, 24 resurfacing receptorbound LDL may be derived from vesicles that have not yet undergone marked acidification. It is not known what causes the release of LDL from these resurfacing vesicles. It would be expected that, even at neutral pH, some LDL would spontaneously dissociate from its receptor and be discharged from the cell. It is also possible that the receptor-bound LDL undergoes modification during transit through the cell so that its affinity toward its receptor is reduced and it dissociates more readily. Agents such as ionophores and weak bases, which block acidification of endosomes, may enhance the resurfacing process by increasing the relative proportion of vesicles in the cell that maintain a neutral pH. Resurfacing of receptor-ligand complexes as a mechanism for exocytosis of internalized ligand has been observed for transferr i n g ^ mannose-terminated glycoconjugates, 9 and galactose-terminated ligands. 27 
' a
In summary, results from the present study suggest that some of the LDL internalized by receptormediated endocytosis is rapidly returned to the cell surface from intraceiiuiar compartments formed early in the endocytic pathway (see Figure 7 fication (Routes 1 and 2). Once the pH of the endosomes becomes acidic, LDL irreversibly dissociates from its receptor. The receptor then returns to the cell surface (Figure 7 , Route 3) and the bulk of the LDL is transported to lysosomes for degradation ( Figure 7 , Route 4). A fraction of LDL may be returned to the cell surface free in vesicular fluid (Route 3). Recycling receptor-rich vesicles subsequently fuse with the plasma membrane, discharging their contents and allowing LDL to dissociate from its receptor. Some of the LDL may be modified during this recycling process. The physiological significance of retro-endocytosis of lipoproteins by cells remains to be elucidated. This process may be significant in atherogenesis, since it could contribute to the delivery of LDL cholesterol to cells, and lead to chemical modification of LDL so that it is recognized by the "scavenger" receptor on macrophages. 29 The present study indicates that retro-endocytosis becomes a quantitatively important alternate pathway in the cellular processing of LDL when the intracellular concentration of undegraded LDL reaches abnormal levels, as in the case of lysosomal deficiencies, or when normally acid intracellular compartments fail to maintain a low pH.
